Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


About the Author

Eric Nielsen

Eric Nielsen

Eric Nielsen is a partner with the law firm of Snell & Wilmer, and represents life science and medical technology companies in all facets of intellectual property law.

Article List

  • A fight worth watching: Genetic and molecular diagnostic patents under fire

    So it is with recent cases regarding patent-eligible subject matter. From Mayo Collaborative Services v. Prometheus Laboratories, Inc. (2012), to Association for Molecular Pathology v. Myriad Genetics, Inc. (2013), to Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015) and other cases, the patentability of certain genetic and molecular diagnostic...

Advertisement. Closing in 15 seconds.